Liabilities / Assets
6th percentile
Higher debt load relative to assets than 6% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
6th percentile
Higher debt load relative to assets than 6% of similar nonprofits.
Liabilities / Revenue
8th percentile
Higher debt load relative to revenue than 8% of similar nonprofits.
Net Margin
96th percentile
Higher net margin than 96% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
89th percentile
Faster asset growth than 89% of similar nonprofits.
Revenue Growth
98th percentile
Faster revenue growth than 98% of similar nonprofits.
Assets
Up$127,531,225
Up $23,928,896 (+23%) from 2016
Net Assets
Up$126,688,059
Up $23,923,092 (+23%) from 2016
Liabilities
Up$843,166
Up $5,804 (+0.7%) from 2016
Revenue
Up$14,940,937
Up $10,381,070 (+228%) from 2016
Expenses
Down$5,081,245
Down $1,569,175 (-24%) from 2016
Net Income
Up$9,859,692
Up $11,950,245 (+572%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
As a supporting organization to the Clayton Foundation for Research (Clayton), the organizations primary mission is to fund medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through Claytons other supporting entities.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.